Pediatric Cancer

PEDIATRIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Maternal Hormonal Contraception, CNS Tumors Not Linked in Children

No significant association was seen between maternal hormonal contraception use and CNS tumors in children younger than 20 years.
FDA Approves Rituxan Plus Chemotherapy for Certain Pediatric Hematologic Cancers

The approval was based on data from the open-label, randomized phase 3 Inter-B-NHL Ritux 2010 trial.
Caregivers of Childhood Cancer Survivors Concerned About COVID-19 Vaccines

Concerns, expressed early in the rollout, included lack of safety and efficacy data, particularly in children with cancer.
Parents Report Challenging Relationships With Pediatric Oncology Clinicians

Asian parents were more likely to report challenging relationships.
CSF-Derived cfDNA Can Be Surrogate for MRD in Medulloblastoma

Researchers were able to detect measurable residual disease at baseline in 64% of patients.

PEDIATRIC CANCER NEWS

DNA

Polygenic Score May Identify Kids, AYAs With AML Who Need Augmented Therapy

January 18, 2022

Child with cancer

Inotuzumab Ozogamicin Deemed Effective in Heavily Pretreated B-ALL

January 14, 2022

Distressed patient

Psychological Distress More Likely in Young Adult Cancer Survivors

January 12, 2022

CAR T-cell therapy

Reinfusion of CAR-T Cells May Prevent Relapse in Acute Lymphoblastic Leukemia

December 26, 2021

Adding Monoclonal Antibody to Induction Could Be New Standard Care for High-Risk Neuroblastoma

December 17, 2021

Next post in Pediatric Cancer

A study of self-reported health status shows the need for physicians to consider the overall well-be

FDA Approves Rituxan Plus Chemotherapy for Certain Pediatric Hematologic Cancers